FRC
FRC Logo
CommunityMarkets
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileHenry Schein, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HSIC
Henry Schein, Inc. Stock AnalysisComprehensive stock analysis for Henry Schein, Inc. (HSIC) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisHSIC
HSIC
Henry Schein, Inc.
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
HSIC
  1. Home
  2. Stocks
  3. Henry Schein, Inc.

Henry Schein, Inc.

🇺🇸HSIC•NASDAQ

Henry Schein, Inc.

🇺🇸HSIC•NASDAQ
Market cap
$9.39B
Sentiment

Your view on HSIC

Mkt Cap
$9.39B
Sentiment
Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Henry Schein, Inc.

Industry
Medical - Distribution
Sector
Healthcare
CEO
Stanley M. Bergman CPA
Headquarters
135 Duryea Road, Melville, NY, US
Industry
Medical - Distribution
Sector
Healthcare
CEO
Stanley M. Bergman CPA
Headquarters
135 Duryea Road, Melville, NY, US
Description

Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. It operates through two segments, Health Care Distribution, and Technology and Value-Added Services.

The Health Care Distribution segment offers dental products, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, dental chairs, delivery units and lights, X-ray supplies and equipment, personal protective equipment, and high-tech and digital restoration equipment, as well as equipment repair services.

This segment also provides medical products comprising branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products, X-ray products, equipment, and vitamins.

The Technology and Value-Added Services segment offers software, technology, and other value-added services that include practice management software systems for dental and medical practitioners.

This segment also provides value-added practice solutions, which comprise financial services on a non-recourse basis, e-services, practice technology, network, and hardware services, as well as continuing education services for practitioners, and consulting and other services. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.

Financial Data

Stock Data

Price chart, volume, and trading data.

What moved it

FRC Fair Value Algorithm

What the FRC Fair Value algorithm says it is worth vs. the current price — FRC's own, on every stock.

About this section

Fair value for Henry Schein, Inc. from FRC's valuation model, read against the market price. HSIC last traded at $84.96, 22.9× trailing earnings — the estimate is read against that market price. The model runs on every stock on the platform and shows the estimate per share and the date it was calculated. A free account covers 3 company valuations a month; a paid subscription is unlimited.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Henry Schein, Inc.. Starting points for Henry Schein, Inc.: P/E 22.9, EPS $3.78, beta 0.86 — an Medical - Distribution name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Henry Schein, Inc.. Henry Schein, Inc. does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Henry Schein, Inc.. Trailing twelve-month EPS for Henry Schein, Inc. stands at $3.78. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 18, 2026 · USD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Current price

—

live quote

Analysts' target

$92.30

average of 10 firms, last 12 months

 

$92.30

Low $64.00

Median $94.50

High $110.00

 

Analyst Ratings

Buy13 firms, last 12 months
  • Strong Buy0
  • Buy8
  • Hold4
  • Sell1
  • Strong Sell0

Earnings Estimate

EPSCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$1.41$1.43$5.48$6.01
Low estimate$1.40$1.39$5.31$5.86
High estimate$1.43$1.49$5.54$6.14
No. of analysts89711
Year-ago EPS$1.34$1.32$3.27—
Growth+5.0%+8.0%+67.7%—

Revenue Estimate

RevenueCurrent QtrDec 2026Next QtrMar 2027Current YearFY Dec 2026Next YearFY Dec 2027
Avg. estimate$3.55B$3.49B$13.84B$14.36B
Low estimate$3.53B$3.47B$13.83B$14.28B
High estimate$3.56B$3.53B$13.86B$14.49B
No. of analysts1071212
Year-ago revenue$3.44B$3.37B$13.18B—
Growth+3.2%+3.5%+5.0%—
Recent analyst actions15 rating and price-target changes, latest Nov 4, 2026 — with the analyst, firm and source

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep from StreetInsider, Benzinga; as of Nov 18, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Henry Schein, Inc.. Henry Schein, Inc. has reported as a listed company since 1995. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold HSIC16 companies · 8 funds
Compare HSIC with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis

Peer companies

Market cap

  • CAHCardinal Health, Inc.Medical - Distribution$65.6B
  • CORCencora, Inc.Medical - Distribution$68.1B
  • MCKMcKesson CorporationMedical - Distribution$127.6B
  • NVSTEnvista Holdings CorpMedical - Instruments & Supplies$3.9B
  • XRAYDENTSPLY SIRONA Inc.Medical - Instruments & Supplies$1.8B

More Medical - Distribution companies

  • IUSDFAS ONE CorporationOTC$1.7B
  • MAHLYMediPal Holdings CorporationOTC$4.2B
  • MCICMultiCorp International, Inc.OTC$131,239
  • MEDOFMedios AGOTC$1.2B
  • MEPDFMediPal Holdings CorporationOTC$3.9B
  • NSVGFNass Valley Gateway Ltd.OTC$3M
  • PDRXPD-Rx Pharmaceuticals, Inc.OTC$6M
  • PGC.AXParagon Care LimitedASX
  • PHRXPharmagen, Inc.OTC$5,171
  • RDGTRidgetech Inc.NASDAQ$4M
  • SAEYYRedcare Pharmacy N.V.OTC$1.4B

ETFs holding Henry Schein, Inc.

% of the fund

  • VOOVanguard S&P 500 ETF$1.0T in assets0.01%
  • VTIVanguard Total Stock Market ETF$689.2B in assets0.01%
  • RSPInvesco S&P 500 Equal Weight ETF$101.8B in assets0.19%
  • VBVanguard Small-Cap ETF$76.9B in assets0.10%
  • CWSAdvisorShares Focused Equity ETF$111M in assets4.48%
  • FLVAmerican Century Focused Large Cap Value ETFAmerican Century Focused Large Cap Value ETFAmerican Century Focused Large Cap Value ETF$405M in assets1.58%
  • XHSState Street SPDR S&P Health Care Services ETF$245M in assets1.56%
  • FXHFirst Trust Health Care AlphaDEX Fund$1.2B in assets0.91%

Largest holders first, then the funds most concentrated in HSIC.

Open Comparable Analysis
Ownership & News

Institutional Ownership

Which funds and firms own the stock.

About this section

Which institutions hold Henry Schein, Inc., and how their positions are changing. At a $9.39B market value, institutional positions materially move Henry Schein, Inc.'s register. Top holders, position sizes, and quarter-over-quarter accumulation or distribution from regulatory filings.

Insider Trading

Recent buying and selling by company executives.

About this section

Buying and selling by Henry Schein, Inc. executives and directors. Shares of Henry Schein, Inc. have traded between $60.56 and $82.49 over the past 52 weeks — context for the timing of the transactions below. Insider transactions as disclosed to regulators, with role, size and date — the clearest read on how the people running the company are positioned.

Senate Trading

U.S. Senator disclosures filed under the STOCK Act.

About this section

U.S. Senate disclosures naming Henry Schein, Inc.. Henry Schein, Inc. is a $9.39B Healthcare company. Senators' reported transactions in this security, alongside the fundamentals — a signal most research platforms leave out entirely.

House Trading

U.S. Representative disclosures filed under the STOCK Act.

About this section

U.S. House of Representatives disclosures naming Henry Schein, Inc.. Representatives' reported transactions in this security, shown next to the company's fundamentals.

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Henry Schein, Inc.. Coverage tracks Henry Schein, Inc. within Medical - Distribution (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Henry Schein, Inc.

HSIC Analysis
Fair
Past4
Growth3
Health3
Profit3
Value1

News

Latest Market News